Text size: AAA

 

Liothyronine

BNF
6.2.1
Status
Black, Red, Amber
Decision Date
September 2016
 

Comments

AMBER: See shared care guideline for depression

BLACK: for hypothyroidism.  See position statement for liothyronine. (Decision date - August 2017)

RED: oncology treatment and for diagnostic purposes in line with the British Thyroid Cancer guidelines. (Decision date - August 2017)

Black Drug Classifications

  • 5: Less cost-effective than current standard therapy

Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating

Amber Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection and initiation of treatment
  • 2: Requiring short or medium term (e.g. 3-6 months) specialist monitoring of efficacy or until the patient is stable

< search again